Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Potticary

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bioanalysis|January 25, 2013
Scripps researchers develop technology for biomarker identification in ulcerative colitisJames Potticary
Bioanalysis|January 12, 2013
Ablynx announce Nanobody(®) deal with Merck & Co., IncJames Potticary
Nanomedicine (London, England)|June 27, 2013
Using nanomedicine to resolve inflammation and prevent tissue damageJames Potticary
Future Medicinal Chemistry|July 17, 2014
New compound could be an ideal candidate for visual restoration in patients with degenerative retinal disordersJames Potticary
Nanomedicine (London, England)|May 18, 2013
Minimal peptides can enhance nanoparticle drug delivery by inhibiting phagocytic clearanceJames Potticary
Bioanalysis|December 11, 2012
UK£7 million donation for the University of LeicesterJames Potticary
Bioanalysis|June 26, 2013
Acquisition of diagnostic tracers to enhance understanding of tau protein in Alzheimer's diseaseJames Potticary
Nanomedicine (London, England)|June 27, 2013
Nanoparticles deliver a sting to HIV‑1 infectivityJames Potticary
Bioanalysis|September 12, 2013
New method created to easily and safely detect prostate cancerJames Potticary
Bioanalysis|May 16, 2014
Scientists develop new biosensor to test for Alzheimer's diseaseJames Potticary
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bioanalysis|January 25, 2013
Scripps researchers develop technology for biomarker identification in ulcerative colitisJames Potticary
Bioanalysis|January 12, 2013
Ablynx announce Nanobody(®) deal with Merck & Co., IncJames Potticary
Nanomedicine (London, England)|June 27, 2013
Using nanomedicine to resolve inflammation and prevent tissue damageJames Potticary
Future Medicinal Chemistry|July 17, 2014
New compound could be an ideal candidate for visual restoration in patients with degenerative retinal disordersJames Potticary
Nanomedicine (London, England)|May 18, 2013
Minimal peptides can enhance nanoparticle drug delivery by inhibiting phagocytic clearanceJames Potticary
Bioanalysis|December 11, 2012
UK£7 million donation for the University of LeicesterJames Potticary
Bioanalysis|June 26, 2013
Acquisition of diagnostic tracers to enhance understanding of tau protein in Alzheimer's diseaseJames Potticary
Nanomedicine (London, England)|June 27, 2013
Nanoparticles deliver a sting to HIV‑1 infectivityJames Potticary
Bioanalysis|September 12, 2013
New method created to easily and safely detect prostate cancerJames Potticary
Bioanalysis|May 16, 2014
Scientists develop new biosensor to test for Alzheimer's diseaseJames Potticary
Pageof 2